Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dhouri, A."'
The project is an online system designed to provide a means of bridging the qualification gap between the academe and the industry in Oman by identifying reasons for the acceptance and nonacceptance of applicants for IT positions. It will therefore a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c644ef73f0cc58fcc2105f709264f756
Autor:
Potter, Victoria T., Krishnamurthy, Pramila, Barber, Linda D., Lim, ZiYi, Kenyon, Michelle, Ireland, Robin M., de Lavallade, Hugues, Dhouri, Abdel, Marsh, Judith C.W., Marcus, Robert, Devereux, Stephen, Ho, Aloysius, Pagliuca, Antonio, Mufti, Ghulam J.
Publikováno v:
In Biology of Blood and Marrow Transplantation January 2014 20(1):111-117
Autor:
L. Bearne, B. Volkmer, A. Dhouri, D. Farran, G. Fisher, M. Galea Holmes, B. Modarai, S. Patel, J. Peacock, C. Sackley, J. Weinman, J. Bieles
Publikováno v:
Physiotherapy. 114:e166
Autor:
Bearne, L., Volkmer, B., Dhouri, A., Farran, D., Fisher, G., Galea Holmes, M., Modarai, B., Patel, S., Peacock, J., Sackley, C., Weinman, J., Bieles, J.
Publikováno v:
In Physiotherapy February 2022 114 Supplement 1:e166-e166
Autor:
Linda Barber, Judith C. W. Marsh, ZiYi Lim, Victoria Potter, Ghulam J. Mufti, Michelle Kenyon, Abdel Dhouri, Pramila Krishnamurthy, Antonio Pagliuca, Robert Marcus, Aloysius Ho, Robin M. Ireland, Stephen Devereux, Hugues de Lavallade
Publikováno v:
Potter, V T, Krishnamurthy, P, Barber, L D, Lim, Z, Kenyon, M, Ireland, R M, de Lavallade, H, Dhouri, A, Marsh, J C W, Marcus, R, Devereux, S, Ho, A, Pagliuca, T & Mufti, G J 2014, ' Long-Term Outcomes of Alemtuzumab-Based Reduced-Intensity Conditioned Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Secondary to Myelodysplastic Syndrome ', BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, vol. 20, no. 1, pp. 111-117 . https://doi.org/10.1016/j.bbmt.2013.10.021
Allogeneic hematopoietic stem cell transplantation (HSCT) with reduced-intensity conditioning (RIC) offers a potential cure for patients with myelodysplastic syndrome (MDS) who are ineligible for standard-intensity regimens. Previously published data